Table 4.
95% confidence intervals (CI) around the estimate of the probability of a DLT for different combinations of dose levels and performance status.
| Age | Dose=33% | Dose=66% | Dose=100% |
|---|---|---|---|
| Performance Status 0 | |||
| 40 | (0.005, 0.010, 0.012) | (0.011, 0.020, 0.036) | (0.020, 0.034, 0.058) |
| 50 | (0.006, 0.012, 0.023) | (0.014, 0.024, 0.041) | (0.024, 0.040, 0.066) |
| 60 | (0.007, 0.014, 0.026) | (0.016, 0.028, 0.047) | (0.028, 0.047, 0.076) |
| 70 | (0.008, 0.016, 0.031) | (0.019, 0.033, 0.056) | (0.033, 0.054, 0.090) |
| 80 | (0.010, 0.019, 0.038) | (0.022, 0.039, 0.068) | (0.037, 0.064, 0.108) |
| Performance Status 1 | |||
| 40 | (0.009, 0.015, 0.025) | (0.020, 0.029, 0.044) | (0.034, 0.049, 0.069) |
| 50 | (0.010, 0.017, 0.028) | (0.025, 0.035, 0.049) | (0.042, 0.057, 0.077) |
| 60 | (0.012, 0.020, 0.033) | (0.029, 0.041, 0.056) | (0.051, 0.067, 0.088) |
| 70 | (0.014, 0.024, 0.039) | (0.034, 0.048, 0.067) | (0.058, 0.078, 0.104) |
| 80 | (0.016, 0.028, 0.047) | (0.038, 0.056, 0.082) | (0.064, 0.091, 0.127) |
| Performance Status 2 | |||
| 40 | (0.011, 0.021, 0.039) | (0.026, 0.043, 0.069) | (0.044, 0.070, 0.110) |
| 50 | (0.014, 0.025, 0.044) | (0.032, 0.050, 0.078) | (0.054, 0.082, 0.122) |
| 60 | (0.017, 0.029, 0.051) | (0.038, 0.059, 0.090) | (0.064, 0.095, 0.140) |
| 70 | (0.019, 0.034, 0.061) | (0.044, 0.068, 0.106) | (0.073, 0.110, 0.163) |
| 80 | (0.022, 0.040, 0.073) | (0.049, 0.080, 0.127) | (0.082, 0.128, 0.193) |
Number of metastatic sites is always 2 which is the median number of sites (lower CI, estimate, upper CI). Dose is represented as percent of maximum tolerated dose (%MTD).